{"Title": "Biologic therapies in patients with neuropsychiatric systemic lupus erythematosus", "Year": 2016, "Source": "Lupus", "Volume": "25", "Issue": 11, "Art.No": null, "PageStart": 1278, "PageEnd": 1279, "CitedBy": 1, "DOI": "10.1177/0961203316631636", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84987619356&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": ["Antibodies, Monoclonal, Humanized", "Biological Products", "Humans", "Lupus Vasculitis, Central Nervous System", "Randomized Controlled Trials as Topic", "Rituximab", "Treatment Outcome"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-84987619356", "SubjectAreas": [["Rheumatology", "MEDI", "2745"]], "AuthorData": {"56669650600": {"Name": "Farinha F.", "AuthorID": "56669650600", "AffiliationID": "115930092", "AffiliationName": "Rheumatology Department, Centro Hospitalar Do Baixo Vouga E.P.E."}, "51863378600": {"Name": "Abrol E.", "AuthorID": "51863378600", "AffiliationID": "60029685", "AffiliationName": "Princess Royal University Hospital (PRUH), King's College Hospital NHS Foundation Trust"}, "57201108555": {"Name": "Isenberg D.A.", "AuthorID": "57201108555", "AffiliationID": "60022148", "AffiliationName": "Centre for Rheumatology, Division of Medicine, University College London, Rayne Building"}}}